Meanwhile, the analysis of the GEO dataset (GSE1456) [33] in which breast cancer patients were treated with TAM monotherapy (n = 90) also displayed the inverse association of HBXIP expression and relapse-free survival (Additional file 4: Figure S1a). The gene discussed is LAMTOR5; the disease is breast carcinoma.